Oxford Biomedica (LON:OXB) Stock Price Passes Below 200-Day Moving Average - Here's What Happened

Shares of Oxford Biomedica plc (LON:OXB - Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 352.05 ($4.77) and traded as low as GBX 332.50 ($4.51). Oxford Biomedica shares last traded at GBX 337.50 ($4.57), with a volume of 125,922 shares trading hands.

Oxford Biomedica Price Performance

The firm has a market capitalization of £354.51 million, a P/E ratio of -2.48 and a beta of 1.09. The stock's fifty day simple moving average is GBX 297.33 and its 200 day simple moving average is GBX 352.05. The company has a debt-to-equity ratio of 166.48, a current ratio of 2.35 and a quick ratio of 1.67.

Oxford Biomedica (LON:OXB - Get Free Report) last issued its quarterly earnings data on Wednesday, April 9th. The biopharmaceutical company reported GBX (41.75) (($0.57)) earnings per share (EPS) for the quarter. Oxford Biomedica had a negative return on equity of 202.50% and a negative net margin of 145.98%. On average, equities research analysts predict that Oxford Biomedica plc will post -31.0799998 EPS for the current year.

About Oxford Biomedica

Oxford Biomedica LSE: OXB is a quality and innovation-led cell and gene therapy CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.